Bioventus (BVS) Other Working Capital Changes (2020 - 2026)

Bioventus has reported Other Working Capital Changes for 7 years, with the latest figure at $275000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes rose 135.26% year-over-year to $275000.0; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (up 52.93% YoY), and the FY2025 full-year result was $1.2 million, down 58.68% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at $275000.0, down from $3.7 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $7.7 million in Q4 2024, with the low at -$9.8 million in Q4 2022.
• Historically, Other Working Capital Changes has averaged -$202529.4 across 5 years, with a median of $569000.0 in 2023.
• The largest YoY upside for Other Working Capital Changes was 1246.57% in 2024 against a maximum downside of 2514.5% in 2024.
• Bioventus' Other Working Capital Changes stood at -$9.8 million in 2022, then soared by 105.79% to $569000.0 in 2023, then soared by 1246.57% to $7.7 million in 2024, then slumped by 51.92% to $3.7 million in 2025, then tumbled by 92.54% to $275000.0 in 2026.
• The last three Other Working Capital Changes figures came in at $275000.0 (Q1 2026), $3.7 million (Q4 2025), and -$3.3 million (Q3 2025), per Business Quant data.